Press Releases

OSLO, Norway, Dec. 4, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that new data from preclinical studies investigating the effect of Betalutin® (177Lu-lilotomab satetraxetan) on non-Hodgkin's lymphoma (NHL) cell lines will be presented in a poster at the 61st American Society of Hematology (ASH) Annual Meeting & Expositi

CLEVELAND, Dec. 4, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 41,550,000 shares of common stock at a price to the public of $3.13 per share,

Brazil represents the largest addressable market in Latin America with a population of 208 million and a potential USD $229 Million patient network for medical cannabis (New Frontier Data) Brazilian national health authority (ANVISA) approves the sale of medical cannabis products for sale by prescription and thro

NEW YORK, Dec. 3, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the pricing of an offering of 3,333,334 shares of its common stock at a public offering price of $30.00 per share in an underwritten

TIANJIN, China, Dec. 3, 2019 /PRNewswire/ -- TIENS Group, one of the world's leading healthcare companies, appeared on the NASDAQ screen in New York's Times Square on November 18, 2019 to display the charm of Chinese enterprise to the world.

PALO ALTO, Calif., Dec. 3, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a price to the public of

ROCKVILLE, Md. and BEIJING, Dec. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Product Administration (NMPA), has approved the clinical trial ap

SAN FRANCISCO, Dec. 3, 2019 /PRNewswire/ -- HealthRIGHT 360 today unveiled its long-awaited Mobile Healthcare Services, extending the storied legacy of the non-profit's origins as the

BALTIMORE, Dec. 3, 2019 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, announced today that its B

PERTH, Australia, Dec. 3, 2019 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF, Zelira), formerly Zelda Therapeutics Ltd, announced today it will bring its HOPE® Franchise to the state of Louisiana with a licensing agreement that will generate immediate revenue through a licensing arrangement